FilingReader Intelligence

PI Industries reports 186% pharma revenue growth in Q1

August 21, 2025 at 07:04 PM UTC•By FilingReader AI

PI Industries reported Q1 FY26 revenue of INR 19,005 million, with 6% year-on-year growth in its domestic business and 186% revenue growth in its pharma platform.

The company aims for single-digit revenue growth for FY26 with sustained EBITDA margins and plans to invest around INR 700-800 crore in capital expenditure.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

PI Industries Limited has informed the exchange that the Investor Education and Protection Fund Authority, Ministry of Corporate Affairs has vide its letter dated July 16, 2025 directed ....August 21, 2025 at 11:51 AM UTC

Supplementary Source Documents

Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter ended June 30, 2025August 21, 2025 at 04:07 PM UTC

PI Industries

BSE:PIIND•Bombay Stock Exchange

RSS feed for PI Industries

News Alerts

Get instant email alerts when PI Industries publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →